Skip to main content
. 2019 Dec 30;9(12):e025627. doi: 10.1136/bmjopen-2018-025627

Figure 5.

Figure 5

Physicians’ assessment of (A) satisfaction, and global assessment of (B) effectiveness and (C) tolerability of linaclotide. Satisfaction data in (A) presented on a scale of 0 (very satisfied) to 10 (totally unsatisfied); Austria, mean 2.9±3.0 points (‘good’ satisfaction); Switzerland, mean 4.6±3.2 points (‘moderate’ satisfaction).